导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.59% | 714/1050 |
| 近一周 | -1.88% | 351/1104 |
| 近一月 | -0.76% | 125/1102 |
| 近一季 | 0.53% | 219/1092 |
| 近半年 | -8.90% | 734/1070 |
| 近一年 | 2.31% | 528/1018 |
| 近两年 | 18.29% | 789/926 |
| 近三年 | 5.18% | 622/834 |
| 成立以来 | 152.26% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.22% 470/1070 |
-11.67% 951/1101 |
- - |
- - |
| 2025 | 12.32% 798/1065 |
-2.07% 914/1014 |
-2.86% 887/1038 |
7.62% 886/1050 |
9.72% 51/1065 |
| 2024 | 5.88% 396/1011 |
2.72% 176/960 |
0.50% 272/983 |
8.92% 724/991 |
-5.84% 719/1011 |
| 2023 | -13.62% 459/952 |
4.40% 357/880 |
-3.31% 402/895 |
-9.40% 562/915 |
-5.55% 564/952 |
| 2022 | -30.52% 642/867 |
-16.10% 313/773 |
1.40% 672/806 |
-16.67% 661/845 |
-2.00% 539/867 |
| 2021 | 8.25% 269/740 |
-4.50% 321/580 |
9.94% 357/659 |
2.54% 174/704 |
0.55% 417/740 |
| 2020 | 63.10% 174/554 |
-1.97% 217/419 |
18.06% 315/466 |
18.78% 67/517 |
18.64% 140/554 |
| 2019 | 55.56% 108/410 |
29.31% 414/1149 |
1.06% 233/1231 |
9.00% 129/390 |
9.21% 185/410 |
| 2018 | -32.83% 252/349 |
- - |
- - |
- - |
-16.59% 943/1080 |
| 2017 | 43.22% 11/285 |
- - |
- - |
- - |
- - |
| 2016 | -18.08% 106/205 |
- - |
- - |
- - |
- - |
| 2015 | 27.82% 49/151 |
- - |
- - |
- - |
- - |
| 2014 | 18.33% 15/24 |
- - |
- - |
- - |
- - |
| 2013 | 28.80% 4/21 |
- - |
- - |
- - |
- - |
| 2012 | 6.17% 75/157 |
- - |
- - |
- - |
- - |
| 2011 | -24.03% 68/102 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 摩根大盘蓝筹股票A VS. 东吴新产业精选股票A(580008) |